CutisPharma, Inc. - Home

800-461-7449

  • CleanRoom1 web
  • Strategy1 web
  • Production web
  • With better science, higher quality, and reliable consistency,
  • And bold innovation that improves patient care,
  • We are Transforming Medicine.

News & Press Releases

    • November 15, 2016

      CutisPharma Unveils New Research and Development Center Massachusetts Senator Bruce Tarr Joins Commemoration of Company’s Acceleration of Pipeline Development for FDA Approvals

      READ MORE

    • October 3, 2016

      CutisPharma Announces Launch of Two New Compounding Kit Families Metronidazole and Baclofen Kits Enable Safe, Easy and Compliant Preparation by Pharmacists

      READ MORE

    • August 1, 2016

      CutisPharma Appoints Steven Dinh as Chief Scientific Officer Filling of Key Role Accelerates Company's Efforts to Develop Drug Portfolio Toward NDA Filings and FDA Approvals

      READ MORE

Information For Customers

  • July, 2016

    Benefits of FIRST®-Vancomycin Presented at 13th Biennial ASA Congress. Stability of antimicrobial activity demonstrated in scientific abstract presentation.

    READ THE ABSTRACT

  • April, 2016

    Superior stability of FIRST®-Vancomycin highlighted in peer-reviewed study. Compared to extemporaneously compounded vancomycin in study published in IJPC.

    READ THE ARTICLE

  •  

    Upcoming Trade Shows
    ASHP

    Dec 4-7 Las Vegas, NV

    ECRM

    Jan 8-11 Ponte Vedra Beach, FL

  • RXMSaveSaveSaveSave
  • RXM3SaveSave
  • Jay AshSaveSaveSaveSave
  • EmarcSaveSaveSaveSave
  • MassBioSaveSaveSaveSave
  • FarewellSaveSaveSaveSave
  • SanchezSaveSaveSaveSave
  • 11.15.16
    Commemoration of Company’s Acceleration of Pipeline Development for FDA Approvals
    Massachusetts Senator Bruce Tarr joined CutisPharma today as it announced the opening of a Research and Development center to house the company’s expanding R&D team. The new center will provide office and laboratory space to facilitate the company’s aggressive plans for developing products for FDA approval under its wholly owned subsidiary, RM Therapeutics.
  • 11.15.16
    Massachusetts Senator Bruce Tarr Helps Celebrate Opening of New R&D Facility
    “I applaud CutisPharma’s initiatives to expand here because they directly impact gains in local employment, enhancements of the region’s economy and ultimately the development of pharmaceuticals that can promote health,” said Tarr, the Senate Minority Leader.
  • 03.02.16
    Massachusetts Housing and Economic Development Secretary Jay Ash Delivers Keynote Address at CutisPharma Ceremony
    Secretary Ash’s address highlighted CutisPharma’s role in economic growth and job creation in Massachusetts and the close partnership that exists in the Commonwealth between industry, academia, and government. The event to commemorate CutisPharma’s new state-of-the-art manufacturing plant was also attended by MassBio Council CEO Bob Coughlin, Massachusetts College of Pharmacy and Health Sciences President Charles Monahan, Jr. and representatives from the offices of Senate Minority Leader Bruce Tarr and Representative James Miceli.
  • 11.13.15 and 11.20.15
    CutisPharma puts others FIRST!
    CutisPharma stepped out of meetings, put away their lab coats, and rolled up their sleeves to join forces with EMARC. Employees from all departments got together to rake leaves and prepare Fall clean up at multiple locations around the Eastern Middlesex area in Massachusetts.
  • 09.28.15
    MassBio stops by to meet one of their newest members
    Massachusetts Biotechnology Consortium President and CEO Robert Coughlin visited. Joined by Executive VP Sara MacDonald and State Government Relations/Federal and State Policy Consultant John Heffernan, the group enjoyed discussing the new relationship between both organizations as well as a tour of the facility.
  • 05.15
    Patriots Hall of Famer Steve Nelson stops by to say Farewell to founders of CutisPharma after 17 years!
    Former Patriot and football legend Steve Nelson stopped by to wish Dr. Indu and Gita Muni a happy farewell. Indu and Gita founded CutisPharma back in 2000 and moved on to new adventures in May of 2015. While their departure was bittersweet they left behind a wonderful foundation which employees continue to build upon.
  • 03.27.15
    Representative Jeffery Sanchez visits CutisPharma
    State Rep Jeffrey Sánchez, Chairman of the Joint Committee on Health Care Financing visited, joined by Sarah Sabshon, Chief of Staff, and Timothy O’Neill, Research Director for the Committee. During their visit, they met with our Executive team and took a group tour of the facility.

LEADING THE WAY TOWARDS A BETTER SOLUTION

FIRST® KITS are intended to help facilitate pharmacist compliance with amended Section 503A of the FDCA and USP <795> compounding procedures and requirements.

home logoproduct

WATCH THE VIDEO · READ THE WHITE PAPER · SEE ALL THE KITS

DRIVING THE FUTURE WITH INNOVATION

Visit soon for exciting updates regarding our Company’s transformation towards developing and commercializing our portfolio of FDA-approved drugs.

home logoRM

 

Connect With Us

Icon TelephoneIcon EMailIcon FacebookIcon TwitterIcon InstagramIcon YouTube